Last reviewed · How we verify
Magnesium sulphate and Lidocaine infusion — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Magnesium sulphate and Lidocaine infusion (Magnesium sulphate and Lidocaine infusion) — Hospital de Base.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Magnesium sulphate and Lidocaine infusion TARGET | Magnesium sulphate and Lidocaine infusion | Hospital de Base | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Magnesium sulphate and Lidocaine infusion CI watch — RSS
- Magnesium sulphate and Lidocaine infusion CI watch — Atom
- Magnesium sulphate and Lidocaine infusion CI watch — JSON
- Magnesium sulphate and Lidocaine infusion alone — RSS
Cite this brief
Drug Landscape (2026). Magnesium sulphate and Lidocaine infusion — Competitive Intelligence Brief. https://druglandscape.com/ci/magnesium-sulphate-and-lidocaine-infusion. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab